Litcius/Paper detail

Design, synthesis, and structure−activity relationship studies of triazolo-pyrimidine derivatives as WRN inhibitors for the treatment of MSI tumors

Qibang Sui, Yuanyang Zhou, Manjia Li, Dan Wang, Rongrong Cui, Xiaoying Cai, Jia‐Bao Liu, Xiaofeng Wang, Dan Teng, Jingyi Zhou, Hui Hou, Sulin Zhang, Mingyue Zheng

2024European Journal of Medicinal Chemistry12 citationsDOIOpen Access PDF

Topics & Concepts

ChemistryPyrimidineStructure–activity relationshipStereochemistryPyrimidine analogueIn vitroCancer researchPharmacologyBiochemistryBiologyMedicineNeuroendocrine Tumor Research AdvancesMetastasis and carcinoma case studies
Design, synthesis, and structure−activity relationship studies of triazolo-pyrimidine derivatives as WRN inhibitors for the treatment of MSI tumors | Litcius